ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Injectable Sumatriptan Market Insights, Forecast to 2030
Published Date: December 2024
|
Report Code: QYRE-Auto-37B8368
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Injectable Sumatriptan Market Insights and Forecast to 2028
BUY CHAPTERS

Global Injectable Sumatriptan Market Insights, Forecast to 2030

Code: QYRE-Auto-37B8368
Report
December 2024
Pages:70
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
GlaxoSmithKline PLC
Pfizer Inc
TEVA
Sun Pharma

Injectable Sumatriptan Market

Sumatriptan injection comes as a solution (liquid) to inject subcutaneously (just under your skin). It is usually used at the first sign of a migraine headache. If your symptoms improve after you use sumatriptan but return after 1 hour or longer, you may use a second dose of sumatriptan.
The global Injectable Sumatriptan market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Injectable Sumatriptan is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Injectable Sumatriptan is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The Europe market for Injectable Sumatriptan is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The global key manufacturers of Injectable Sumatriptan include GlaxoSmithKline, Pfizer, Teva and Sun Pharma, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Report Covers:
This report presents an overview of global market for Injectable Sumatriptan, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Injectable Sumatriptan, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Injectable Sumatriptan, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Injectable Sumatriptan sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Injectable Sumatriptan market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Injectable Sumatriptan sales, projected growth trends, production technology, application and end-user industry.
Market Segmentation

Scope of Injectable Sumatriptan Market Report

Report Metric Details
Report Name Injectable Sumatriptan Market
Segment by Type
  • 4mg
  • 6mg
  • Others
Segment by Application
  • Hospitals
  • Clinics
  • Others
Segment by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Teva, Sun Pharma
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Sales (consumption), revenue of Injectable Sumatriptan in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 3: Detailed analysis of Injectable Sumatriptan manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
  • Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
  • Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Injectable Sumatriptan sales, revenue, price, gross margin, and recent development, etc.
  • Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
  • Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 14: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Injectable Sumatriptan Market report?

Ans: The main players in the Injectable Sumatriptan Market are Teva, Sun Pharma

What are the Application segmentation covered in the Injectable Sumatriptan Market report?

Ans: The Applications covered in the Injectable Sumatriptan Market report are Hospitals, Clinics, Others

What are the Type segmentation covered in the Injectable Sumatriptan Market report?

Ans: The Types covered in the Injectable Sumatriptan Market report are 4mg, 6mg, Others

Recommended Reports

Migraine Solutions

Injectable Pharmaceuticals

Ophthalmic Treatments

1 Study Coverage
1.1 Injectable Sumatriptan Product Introduction
1.2 Market by Type
1.2.1 Global Injectable Sumatriptan Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 4mg
1.2.3 6mg
1.2.4 Others
1.3 Market by Application
1.3.1 Global Injectable Sumatriptan Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Injectable Sumatriptan Sales Estimates and Forecasts 2019-2030
2.2 Global Injectable Sumatriptan Revenue by Region
2.2.1 Global Injectable Sumatriptan Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Injectable Sumatriptan Revenue by Region (2019-2024)
2.2.3 Global Injectable Sumatriptan Revenue by Region (2025-2030)
2.2.4 Global Injectable Sumatriptan Revenue Market Share by Region (2019-2030)
2.3 Global Injectable Sumatriptan Sales Estimates and Forecasts 2019-2030
2.4 Global Injectable Sumatriptan Sales by Region
2.4.1 Global Injectable Sumatriptan Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Injectable Sumatriptan Sales by Region (2019-2024)
2.4.3 Global Injectable Sumatriptan Sales by Region (2025-2030)
2.4.4 Global Injectable Sumatriptan Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Injectable Sumatriptan Sales by Manufacturers
3.1.1 Global Injectable Sumatriptan Sales by Manufacturers (2019-2024)
3.1.2 Global Injectable Sumatriptan Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Injectable Sumatriptan in 2023
3.2 Global Injectable Sumatriptan Revenue by Manufacturers
3.2.1 Global Injectable Sumatriptan Revenue by Manufacturers (2019-2024)
3.2.2 Global Injectable Sumatriptan Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Injectable Sumatriptan Revenue in 2023
3.3 Global Key Players of Injectable Sumatriptan, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Injectable Sumatriptan Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Injectable Sumatriptan Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Injectable Sumatriptan, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Injectable Sumatriptan, Product Offered and Application
3.8 Global Key Manufacturers of Injectable Sumatriptan, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Injectable Sumatriptan Sales by Type
4.1.1 Global Injectable Sumatriptan Historical Sales by Type (2019-2024)
4.1.2 Global Injectable Sumatriptan Forecasted Sales by Type (2025-2030)
4.1.3 Global Injectable Sumatriptan Sales Market Share by Type (2019-2030)
4.2 Global Injectable Sumatriptan Revenue by Type
4.2.1 Global Injectable Sumatriptan Historical Revenue by Type (2019-2024)
4.2.2 Global Injectable Sumatriptan Forecasted Revenue by Type (2025-2030)
4.2.3 Global Injectable Sumatriptan Revenue Market Share by Type (2019-2030)
4.3 Global Injectable Sumatriptan Price by Type
4.3.1 Global Injectable Sumatriptan Price by Type (2019-2024)
4.3.2 Global Injectable Sumatriptan Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Injectable Sumatriptan Sales by Application
5.1.1 Global Injectable Sumatriptan Historical Sales by Application (2019-2024)
5.1.2 Global Injectable Sumatriptan Forecasted Sales by Application (2025-2030)
5.1.3 Global Injectable Sumatriptan Sales Market Share by Application (2019-2030)
5.2 Global Injectable Sumatriptan Revenue by Application
5.2.1 Global Injectable Sumatriptan Historical Revenue by Application (2019-2024)
5.2.2 Global Injectable Sumatriptan Forecasted Revenue by Application (2025-2030)
5.2.3 Global Injectable Sumatriptan Revenue Market Share by Application (2019-2030)
5.3 Global Injectable Sumatriptan Price by Application
5.3.1 Global Injectable Sumatriptan Price by Application (2019-2024)
5.3.2 Global Injectable Sumatriptan Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Injectable Sumatriptan Market Size by Type
6.1.1 US & Canada Injectable Sumatriptan Sales by Type (2019-2030)
6.1.2 US & Canada Injectable Sumatriptan Revenue by Type (2019-2030)
6.2 US & Canada Injectable Sumatriptan Market Size by Application
6.2.1 US & Canada Injectable Sumatriptan Sales by Application (2019-2030)
6.2.2 US & Canada Injectable Sumatriptan Revenue by Application (2019-2030)
6.3 US & Canada Injectable Sumatriptan Market Size by Country
6.3.1 US & Canada Injectable Sumatriptan Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Injectable Sumatriptan Sales by Country (2019-2030)
6.3.3 US & Canada Injectable Sumatriptan Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Injectable Sumatriptan Market Size by Type
7.1.1 Europe Injectable Sumatriptan Sales by Type (2019-2030)
7.1.2 Europe Injectable Sumatriptan Revenue by Type (2019-2030)
7.2 Europe Injectable Sumatriptan Market Size by Application
7.2.1 Europe Injectable Sumatriptan Sales by Application (2019-2030)
7.2.2 Europe Injectable Sumatriptan Revenue by Application (2019-2030)
7.3 Europe Injectable Sumatriptan Market Size by Country
7.3.1 Europe Injectable Sumatriptan Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Injectable Sumatriptan Sales by Country (2019-2030)
7.3.3 Europe Injectable Sumatriptan Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Injectable Sumatriptan Market Size
8.1.1 China Injectable Sumatriptan Sales (2019-2030)
8.1.2 China Injectable Sumatriptan Revenue (2019-2030)
8.2 China Injectable Sumatriptan Market Size by Application
8.2.1 China Injectable Sumatriptan Sales by Application (2019-2030)
8.2.2 China Injectable Sumatriptan Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Injectable Sumatriptan Market Size by Type
9.1.1 Asia Injectable Sumatriptan Sales by Type (2019-2030)
9.1.2 Asia Injectable Sumatriptan Revenue by Type (2019-2030)
9.2 Asia Injectable Sumatriptan Market Size by Application
9.2.1 Asia Injectable Sumatriptan Sales by Application (2019-2030)
9.2.2 Asia Injectable Sumatriptan Revenue by Application (2019-2030)
9.3 Asia Injectable Sumatriptan Sales by Region
9.3.1 Asia Injectable Sumatriptan Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Injectable Sumatriptan Revenue by Region (2019-2030)
9.3.3 Asia Injectable Sumatriptan Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Injectable Sumatriptan Market Size by Type
10.1.1 Middle East, Africa and Latin America Injectable Sumatriptan Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Injectable Sumatriptan Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Injectable Sumatriptan Market Size by Application
10.2.1 Middle East, Africa and Latin America Injectable Sumatriptan Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Injectable Sumatriptan Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Injectable Sumatriptan Sales by Country
10.3.1 Middle East, Africa and Latin America Injectable Sumatriptan Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Injectable Sumatriptan Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Injectable Sumatriptan Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Company Information
11.1.2 GlaxoSmithKline Overview
11.1.3 GlaxoSmithKline Injectable Sumatriptan Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 GlaxoSmithKline Injectable Sumatriptan Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 GlaxoSmithKline Recent Developments
11.2 Pfizer
11.2.1 Pfizer Company Information
11.2.2 Pfizer Overview
11.2.3 Pfizer Injectable Sumatriptan Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 Pfizer Injectable Sumatriptan Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Pfizer Recent Developments
11.3 Teva
11.3.1 Teva Company Information
11.3.2 Teva Overview
11.3.3 Teva Injectable Sumatriptan Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 Teva Injectable Sumatriptan Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Teva Recent Developments
11.4 Sun Pharma
11.4.1 Sun Pharma Company Information
11.4.2 Sun Pharma Overview
11.4.3 Sun Pharma Injectable Sumatriptan Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 Sun Pharma Injectable Sumatriptan Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Sun Pharma Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Injectable Sumatriptan Industry Chain Analysis
12.2 Injectable Sumatriptan Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Injectable Sumatriptan Production Mode & Process
12.4 Injectable Sumatriptan Sales and Marketing
12.4.1 Injectable Sumatriptan Sales Channels
12.4.2 Injectable Sumatriptan Distributors
12.5 Injectable Sumatriptan Customers
13 Market Dynamics
13.1 Injectable Sumatriptan Industry Trends
13.2 Injectable Sumatriptan Market Drivers
13.3 Injectable Sumatriptan Market Challenges
13.4 Injectable Sumatriptan Market Restraints
14 Key Findings in The Global Injectable Sumatriptan Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
FEATURED COMPANIES
GlaxoSmithKline PLC
Pfizer Inc
TEVA
Sun Pharma
List of Tables
    Table 1. Global Injectable Sumatriptan Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Table 2. Major Manufacturers of 4mg
    Table 3. Major Manufacturers of 6mg
    Table 4. Major Manufacturers of Others
    Table 5. Global Injectable Sumatriptan Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Table 6. Global Injectable Sumatriptan Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 7. Global Injectable Sumatriptan Revenue by Region (2019-2024) & (US$ Million)
    Table 8. Global Injectable Sumatriptan Revenue by Region (2025-2030) & (US$ Million)
    Table 9. Global Injectable Sumatriptan Revenue Market Share by Region (2019-2024)
    Table 10. Global Injectable Sumatriptan Revenue Market Share by Region (2025-2030)
    Table 11. Global Injectable Sumatriptan Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 12. Global Injectable Sumatriptan Sales by Region (2019-2024) & (K Units)
    Table 13. Global Injectable Sumatriptan Sales by Region (2025-2030) & (K Units)
    Table 14. Global Injectable Sumatriptan Sales Market Share by Region (2019-2024)
    Table 15. Global Injectable Sumatriptan Sales Market Share by Region (2025-2030)
    Table 16. Global Injectable Sumatriptan Sales by Manufacturers (2019-2024) & (K Units)
    Table 17. Global Injectable Sumatriptan Sales Share by Manufacturers (2019-2024)
    Table 18. Global Injectable Sumatriptan Revenue by Manufacturers (2019-2024) & (US$ Million)
    Table 19. Global Injectable Sumatriptan Revenue Share by Manufacturers (2019-2024)
    Table 20. Global Key Players of Injectable Sumatriptan, Industry Ranking, 2022 VS 2023 VS 2024
    Table 21. Injectable Sumatriptan Price by Manufacturers 2019-2024 (US$/Unit)
    Table 22. Global Injectable Sumatriptan Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 23. Global Injectable Sumatriptan by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Injectable Sumatriptan as of 2023)
    Table 24. Global Key Manufacturers of Injectable Sumatriptan, Manufacturing Base Distribution and Headquarters
    Table 25. Global Key Manufacturers of Injectable Sumatriptan, Product Offered and Application
    Table 26. Global Key Manufacturers of Injectable Sumatriptan, Date of Enter into This Industry
    Table 27. Mergers & Acquisitions, Expansion Plans
    Table 28. Global Injectable Sumatriptan Sales by Type (2019-2024) & (K Units)
    Table 29. Global Injectable Sumatriptan Sales by Type (2025-2030) & (K Units)
    Table 30. Global Injectable Sumatriptan Sales Share by Type (2019-2024)
    Table 31. Global Injectable Sumatriptan Sales Share by Type (2025-2030)
    Table 32. Global Injectable Sumatriptan Revenue by Type (2019-2024) & (US$ Million)
    Table 33. Global Injectable Sumatriptan Revenue by Type (2025-2030) & (US$ Million)
    Table 34. Global Injectable Sumatriptan Revenue Share by Type (2019-2024)
    Table 35. Global Injectable Sumatriptan Revenue Share by Type (2025-2030)
    Table 36. Injectable Sumatriptan Price by Type (2019-2024) & (US$/Unit)
    Table 37. Global Injectable Sumatriptan Price Forecast by Type (2025-2030) & (US$/Unit)
    Table 38. Global Injectable Sumatriptan Sales by Application (2019-2024) & (K Units)
    Table 39. Global Injectable Sumatriptan Sales by Application (2025-2030) & (K Units)
    Table 40. Global Injectable Sumatriptan Sales Share by Application (2019-2024)
    Table 41. Global Injectable Sumatriptan Sales Share by Application (2025-2030)
    Table 42. Global Injectable Sumatriptan Revenue by Application (2019-2024) & (US$ Million)
    Table 43. Global Injectable Sumatriptan Revenue by Application (2025-2030) & (US$ Million)
    Table 44. Global Injectable Sumatriptan Revenue Share by Application (2019-2024)
    Table 45. Global Injectable Sumatriptan Revenue Share by Application (2025-2030)
    Table 46. Injectable Sumatriptan Price by Application (2019-2024) & (US$/Unit)
    Table 47. Global Injectable Sumatriptan Price Forecast by Application (2025-2030) & (US$/Unit)
    Table 48. US & Canada Injectable Sumatriptan Sales by Type (2019-2024) & (K Units)
    Table 49. US & Canada Injectable Sumatriptan Sales by Type (2025-2030) & (K Units)
    Table 50. US & Canada Injectable Sumatriptan Revenue by Type (2019-2024) & (US$ Million)
    Table 51. US & Canada Injectable Sumatriptan Revenue by Type (2025-2030) & (US$ Million)
    Table 52. US & Canada Injectable Sumatriptan Sales by Application (2019-2024) & (K Units)
    Table 53. US & Canada Injectable Sumatriptan Sales by Application (2025-2030) & (K Units)
    Table 54. US & Canada Injectable Sumatriptan Revenue by Application (2019-2024) & (US$ Million)
    Table 55. US & Canada Injectable Sumatriptan Revenue by Application (2025-2030) & (US$ Million)
    Table 56. US & Canada Injectable Sumatriptan Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 57. US & Canada Injectable Sumatriptan Revenue by Country (2019-2024) & (US$ Million)
    Table 58. US & Canada Injectable Sumatriptan Revenue by Country (2025-2030) & (US$ Million)
    Table 59. US & Canada Injectable Sumatriptan Sales by Country (2019-2024) & (K Units)
    Table 60. US & Canada Injectable Sumatriptan Sales by Country (2025-2030) & (K Units)
    Table 61. Europe Injectable Sumatriptan Sales by Type (2019-2024) & (K Units)
    Table 62. Europe Injectable Sumatriptan Sales by Type (2025-2030) & (K Units)
    Table 63. Europe Injectable Sumatriptan Revenue by Type (2019-2024) & (US$ Million)
    Table 64. Europe Injectable Sumatriptan Revenue by Type (2025-2030) & (US$ Million)
    Table 65. Europe Injectable Sumatriptan Sales by Application (2019-2024) & (K Units)
    Table 66. Europe Injectable Sumatriptan Sales by Application (2025-2030) & (K Units)
    Table 67. Europe Injectable Sumatriptan Revenue by Application (2019-2024) & (US$ Million)
    Table 68. Europe Injectable Sumatriptan Revenue by Application (2025-2030) & (US$ Million)
    Table 69. Europe Injectable Sumatriptan Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 70. Europe Injectable Sumatriptan Revenue by Country (2019-2024) & (US$ Million)
    Table 71. Europe Injectable Sumatriptan Revenue by Country (2025-2030) & (US$ Million)
    Table 72. Europe Injectable Sumatriptan Sales by Country (2019-2024) & (K Units)
    Table 73. Europe Injectable Sumatriptan Sales by Country (2025-2030) & (K Units)
    Table 74. China Injectable Sumatriptan Sales by Type (2019-2024) & (K Units)
    Table 75. China Injectable Sumatriptan Sales by Type (2025-2030) & (K Units)
    Table 76. China Injectable Sumatriptan Revenue by Type (2019-2024) & (US$ Million)
    Table 77. China Injectable Sumatriptan Revenue by Type (2025-2030) & (US$ Million)
    Table 78. China Injectable Sumatriptan Sales by Application (2019-2024) & (K Units)
    Table 79. China Injectable Sumatriptan Sales by Application (2025-2030) & (K Units)
    Table 80. China Injectable Sumatriptan Revenue by Application (2019-2024) & (US$ Million)
    Table 81. China Injectable Sumatriptan Revenue by Application (2025-2030) & (US$ Million)
    Table 82. Asia Injectable Sumatriptan Sales by Type (2019-2024) & (K Units)
    Table 83. Asia Injectable Sumatriptan Sales by Type (2025-2030) & (K Units)
    Table 84. Asia Injectable Sumatriptan Revenue by Type (2019-2024) & (US$ Million)
    Table 85. Asia Injectable Sumatriptan Revenue by Type (2025-2030) & (US$ Million)
    Table 86. Asia Injectable Sumatriptan Sales by Application (2019-2024) & (K Units)
    Table 87. Asia Injectable Sumatriptan Sales by Application (2025-2030) & (K Units)
    Table 88. Asia Injectable Sumatriptan Revenue by Application (2019-2024) & (US$ Million)
    Table 89. Asia Injectable Sumatriptan Revenue by Application (2025-2030) & (US$ Million)
    Table 90. Asia Injectable Sumatriptan Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 91. Asia Injectable Sumatriptan Revenue by Region (2019-2024) & (US$ Million)
    Table 92. Asia Injectable Sumatriptan Revenue by Region (2025-2030) & (US$ Million)
    Table 93. Asia Injectable Sumatriptan Sales by Region (2019-2024) & (K Units)
    Table 94. Asia Injectable Sumatriptan Sales by Region (2025-2030) & (K Units)
    Table 95. Middle East, Africa and Latin America Injectable Sumatriptan Sales by Type (2019-2024) & (K Units)
    Table 96. Middle East, Africa and Latin America Injectable Sumatriptan Sales by Type (2025-2030) & (K Units)
    Table 97. Middle East, Africa and Latin America Injectable Sumatriptan Revenue by Type (2019-2024) & (US$ Million)
    Table 98. Middle East, Africa and Latin America Injectable Sumatriptan Revenue by Type (2025-2030) & (US$ Million)
    Table 99. Middle East, Africa and Latin America Injectable Sumatriptan Sales by Application (2019-2024) & (K Units)
    Table 100. Middle East, Africa and Latin America Injectable Sumatriptan Sales by Application (2025-2030) & (K Units)
    Table 101. Middle East, Africa and Latin America Injectable Sumatriptan Revenue by Application (2019-2024) & (US$ Million)
    Table 102. Middle East, Africa and Latin America Injectable Sumatriptan Revenue by Application (2025-2030) & (US$ Million)
    Table 103. Middle East, Africa and Latin America Injectable Sumatriptan Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 104. Middle East, Africa and Latin America Injectable Sumatriptan Revenue by Country (2019-2024) & (US$ Million)
    Table 105. Middle East, Africa and Latin America Injectable Sumatriptan Revenue by Country (2025-2030) & (US$ Million)
    Table 106. Middle East, Africa and Latin America Injectable Sumatriptan Sales by Country (2019-2024) & (K Units)
    Table 107. Middle East, Africa and Latin America Injectable Sumatriptan Sales by Country (2025-2030) & (K Units)
    Table 108. GlaxoSmithKline Company Information
    Table 109. GlaxoSmithKline Description and Major Businesses
    Table 110. GlaxoSmithKline Injectable Sumatriptan Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 111. GlaxoSmithKline Injectable Sumatriptan Product Model Numbers, Pictures, Descriptions and Specifications
    Table 112. GlaxoSmithKline Recent Developments
    Table 113. Pfizer Company Information
    Table 114. Pfizer Description and Major Businesses
    Table 115. Pfizer Injectable Sumatriptan Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 116. Pfizer Injectable Sumatriptan Product Model Numbers, Pictures, Descriptions and Specifications
    Table 117. Pfizer Recent Developments
    Table 118. Teva Company Information
    Table 119. Teva Description and Major Businesses
    Table 120. Teva Injectable Sumatriptan Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 121. Teva Injectable Sumatriptan Product Model Numbers, Pictures, Descriptions and Specifications
    Table 122. Teva Recent Developments
    Table 123. Sun Pharma Company Information
    Table 124. Sun Pharma Description and Major Businesses
    Table 125. Sun Pharma Injectable Sumatriptan Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 126. Sun Pharma Injectable Sumatriptan Product Model Numbers, Pictures, Descriptions and Specifications
    Table 127. Sun Pharma Recent Developments
    Table 128. Key Raw Materials Lists
    Table 129. Raw Materials Key Suppliers Lists
    Table 130. Injectable Sumatriptan Distributors List
    Table 131. Injectable Sumatriptan Customers List
    Table 132. Injectable Sumatriptan Market Trends
    Table 133. Injectable Sumatriptan Market Drivers
    Table 134. Injectable Sumatriptan Market Challenges
    Table 135. Injectable Sumatriptan Market Restraints
    Table 136. Research Programs/Design for This Report
    Table 137. Key Data Information from Secondary Sources
    Table 138. Key Data Information from Primary Sources
List of Figures
    Figure 1. Injectable Sumatriptan Product Picture
    Figure 2. Global Injectable Sumatriptan Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Injectable Sumatriptan Market Share by Type in 2023 & 2030
    Figure 4. 4mg Product Picture
    Figure 5. 6mg Product Picture
    Figure 6. Others Product Picture
    Figure 7. Global Injectable Sumatriptan Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 8. Global Injectable Sumatriptan Market Share by Application in 2023 & 2030
    Figure 9. Hospitals
    Figure 10. Clinics
    Figure 11. Others
    Figure 12. Injectable Sumatriptan Report Years Considered
    Figure 13. Global Injectable Sumatriptan Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 14. Global Injectable Sumatriptan Revenue 2019-2030 (US$ Million)
    Figure 15. Global Injectable Sumatriptan Revenue Market Share by Region in Percentage: 2023 Versus 2030
    Figure 16. Global Injectable Sumatriptan Revenue Market Share by Region (2019-2030)
    Figure 17. Global Injectable Sumatriptan Sales 2019-2030 ((K Units)
    Figure 18. Global Injectable Sumatriptan Sales Market Share by Region (2019-2030)
    Figure 19. US & Canada Injectable Sumatriptan Sales YoY (2019-2030) & (K Units)
    Figure 20. US & Canada Injectable Sumatriptan Revenue YoY (2019-2030) & (US$ Million)
    Figure 21. Europe Injectable Sumatriptan Sales YoY (2019-2030) & (K Units)
    Figure 22. Europe Injectable Sumatriptan Revenue YoY (2019-2030) & (US$ Million)
    Figure 23. China Injectable Sumatriptan Sales YoY (2019-2030) & (K Units)
    Figure 24. China Injectable Sumatriptan Revenue YoY (2019-2030) & (US$ Million)
    Figure 25. Asia (excluding China) Injectable Sumatriptan Sales YoY (2019-2030) & (K Units)
    Figure 26. Asia (excluding China) Injectable Sumatriptan Revenue YoY (2019-2030) & (US$ Million)
    Figure 27. Middle East, Africa and Latin America Injectable Sumatriptan Sales YoY (2019-2030) & (K Units)
    Figure 28. Middle East, Africa and Latin America Injectable Sumatriptan Revenue YoY (2019-2030) & (US$ Million)
    Figure 29. The Injectable Sumatriptan Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
    Figure 30. The Top 5 and 10 Largest Manufacturers of Injectable Sumatriptan in the World: Market Share by Injectable Sumatriptan Revenue in 2023
    Figure 31. Global Injectable Sumatriptan Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 32. Global Injectable Sumatriptan Sales Market Share by Type (2019-2030)
    Figure 33. Global Injectable Sumatriptan Revenue Market Share by Type (2019-2030)
    Figure 34. Global Injectable Sumatriptan Sales Market Share by Application (2019-2030)
    Figure 35. Global Injectable Sumatriptan Revenue Market Share by Application (2019-2030)
    Figure 36. US & Canada Injectable Sumatriptan Sales Market Share by Type (2019-2030)
    Figure 37. US & Canada Injectable Sumatriptan Revenue Market Share by Type (2019-2030)
    Figure 38. US & Canada Injectable Sumatriptan Sales Market Share by Application (2019-2030)
    Figure 39. US & Canada Injectable Sumatriptan Revenue Market Share by Application (2019-2030)
    Figure 40. US & Canada Injectable Sumatriptan Revenue Share by Country (2019-2030)
    Figure 41. US & Canada Injectable Sumatriptan Sales Share by Country (2019-2030)
    Figure 42. U.S. Injectable Sumatriptan Revenue (2019-2030) & (US$ Million)
    Figure 43. Canada Injectable Sumatriptan Revenue (2019-2030) & (US$ Million)
    Figure 44. Europe Injectable Sumatriptan Sales Market Share by Type (2019-2030)
    Figure 45. Europe Injectable Sumatriptan Revenue Market Share by Type (2019-2030)
    Figure 46. Europe Injectable Sumatriptan Sales Market Share by Application (2019-2030)
    Figure 47. Europe Injectable Sumatriptan Revenue Market Share by Application (2019-2030)
    Figure 48. Europe Injectable Sumatriptan Revenue Share by Country (2019-2030)
    Figure 49. Europe Injectable Sumatriptan Sales Share by Country (2019-2030)
    Figure 50. Germany Injectable Sumatriptan Revenue (2019-2030) & (US$ Million)
    Figure 51. France Injectable Sumatriptan Revenue (2019-2030) & (US$ Million)
    Figure 52. U.K. Injectable Sumatriptan Revenue (2019-2030) & (US$ Million)
    Figure 53. Italy Injectable Sumatriptan Revenue (2019-2030) & (US$ Million)
    Figure 54. Russia Injectable Sumatriptan Revenue (2019-2030) & (US$ Million)
    Figure 55. China Injectable Sumatriptan Sales Market Share by Type (2019-2030)
    Figure 56. China Injectable Sumatriptan Revenue Market Share by Type (2019-2030)
    Figure 57. China Injectable Sumatriptan Sales Market Share by Application (2019-2030)
    Figure 58. China Injectable Sumatriptan Revenue Market Share by Application (2019-2030)
    Figure 59. Asia Injectable Sumatriptan Sales Market Share by Type (2019-2030)
    Figure 60. Asia Injectable Sumatriptan Revenue Market Share by Type (2019-2030)
    Figure 61. Asia Injectable Sumatriptan Sales Market Share by Application (2019-2030)
    Figure 62. Asia Injectable Sumatriptan Revenue Market Share by Application (2019-2030)
    Figure 63. Asia Injectable Sumatriptan Revenue Share by Region (2019-2030)
    Figure 64. Asia Injectable Sumatriptan Sales Share by Region (2019-2030)
    Figure 65. Japan Injectable Sumatriptan Revenue (2019-2030) & (US$ Million)
    Figure 66. South Korea Injectable Sumatriptan Revenue (2019-2030) & (US$ Million)
    Figure 67. China Taiwan Injectable Sumatriptan Revenue (2019-2030) & (US$ Million)
    Figure 68. Southeast Asia Injectable Sumatriptan Revenue (2019-2030) & (US$ Million)
    Figure 69. India Injectable Sumatriptan Revenue (2019-2030) & (US$ Million)
    Figure 70. Middle East, Africa and Latin America Injectable Sumatriptan Sales Market Share by Type (2019-2030)
    Figure 71. Middle East, Africa and Latin America Injectable Sumatriptan Revenue Market Share by Type (2019-2030)
    Figure 72. Middle East, Africa and Latin America Injectable Sumatriptan Sales Market Share by Application (2019-2030)
    Figure 73. Middle East, Africa and Latin America Injectable Sumatriptan Revenue Market Share by Application (2019-2030)
    Figure 74. Middle East, Africa and Latin America Injectable Sumatriptan Revenue Share by Country (2019-2030)
    Figure 75. Middle East, Africa and Latin America Injectable Sumatriptan Sales Share by Country (2019-2030)
    Figure 76. Brazil Injectable Sumatriptan Revenue (2019-2030) & (US$ Million)
    Figure 77. Mexico Injectable Sumatriptan Revenue (2019-2030) & (US$ Million)
    Figure 78. Turkey Injectable Sumatriptan Revenue (2019-2030) & (US$ Million)
    Figure 79. Israel Injectable Sumatriptan Revenue (2019-2030) & (US$ Million)
    Figure 80. GCC Countries Injectable Sumatriptan Revenue (2019-2030) & (US$ Million)
    Figure 81. Injectable Sumatriptan Value Chain
    Figure 82. Injectable Sumatriptan Production Process
    Figure 83. Channels of Distribution
    Figure 84. Distributors Profiles
    Figure 85. Bottom-up and Top-down Approaches for This Report
    Figure 86. Data Triangulation
    Figure 87. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS

Global Sumatriptan Autoinjector Market Insights Forecast to 2030
Global Zolmitriptan Market Insights Forecast to 2030
Global Triptans for Migraine Headaches Market Research Report 2025
Global Subcutaneous Injection Immunoglobulin Market Insights Forecast to 2030
Global Triptan Market Insights Forecast to 2030
Global Naratriptan Hydrochloride Market Research Report 2024
Global Rizatriptan Market Research Report 2024
Migraine Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Sumatriptan Succinate Market Research Report 2025
OTC Migraine Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Subcutaneous Injection Market Research Report 2024
Sumatriptan Succinate API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Acute Migraine Treatments Market Research Report 2024
Migraine Medication Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Electronic Aspirin Market Research Report 2024
Global Subcutaneous Immunoglobulins Market Research Report 2025
Global Frovatriptan Succinate Tablets Market Research Report 2024
Global Almotriptan Malate Reagent Market Research Report 2024
Global Eletriptan Market Insights Forecast to 2030
OTC Migraine Medication Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions